+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06580002

A Phase 2a Study of Riluzole to Improve Brain-Derived Neurotrophic Factor Levels and Cognitive Function in Adults With Cancer-Related Cognitive Impairment

Led by University of California, Irvine · Updated on 2026-07-14

75

Participants Needed

1

Research Sites

21 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating riluzole therapy in a phase 2a randomized, double-blinded, placebo-controlled pilot trial to study its effect on brain-derived neurotrophic factor BDNF levels in cancer survivors or patients who have undergone whole brain radiation for tumors and experience cancer-related cognitive impairment. The trial aims to understand how riluzole impacts cognitive function in these patients. This study is led by the University of California, Irvine. Participants are randomly assigned to take either 50 mg of riluzole or a matching placebo capsule twice daily for 8 weeks. The trial includes two groups one receiving riluzole and the other receiving placebo. Both treatments are given orally. The study lasts 8 weeks, during which the effects on circulating BDNF levels and cognitive function are monitored. Throughout the study, participants will be assessed for changes in BDNF levels and cognitive function using questionnaires and computerized tests. Researchers will measure cognitive function scores using FACT-Cog and CANTAB tools at the 8-week mark. Safety and tolerability are monitored, and participants are expected to complete questionnaires and assessments in English, Chinese, Korean, Vietnamese, or Spanish. The total participation time is about 8 weeks, with regular follow-ups during this period.

CONDITIONS

Brief Title

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Research Team

C

Chao Family Comprehensive Cancer Center University of California, Irvine

U

University of California Irvine Medical

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here